International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell total assets
Total assets on the balance sheet at the end of each period.
International Stem Cell's total assets was $5.06M at Jun 30, 2026. For fiscal 2025 it was $4.82M, down 6.8% from the year before. Over ten years it grew -3.9% a year on average. The highest annual figure on record is $9.93M in fiscal 2010.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.82M | -6.8% |
| FY2024 | Dec 31, 2024 | $5.17M | -4.0% |
| FY2023 | Dec 31, 2023 | $5.39M | +5.0% |
| FY2022 | Dec 31, 2022 | $5.14M | +3.8% |
| FY2021 | Dec 31, 2021 | $4.95M | -6.4% |
| FY2020 | Dec 31, 2020 | $5.29M | -20.1% |
| FY2019 | Dec 31, 2019 | $6.62M | -15.1% |
| FY2018 | Dec 31, 2018 | $7.80M | +13.6% |
| FY2017 | Dec 31, 2017 | $6.86M | -2.6% |
| FY2016 | Dec 31, 2016 | $7.05M | -1.3% |
| FY2015 | Dec 31, 2015 | $7.14M | -0.6% |
| FY2014 | Dec 31, 2014 | $7.18M | -7.2% |
| FY2013 | Dec 31, 2013 | $7.74M | +44.1% |
| FY2012 | Dec 31, 2012 | $5.37M | -6.4% |
| FY2011 | Dec 31, 2011 | $5.74M | -42.2% |
| FY2010 | Dec 31, 2010 | $9.93M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.06M | -8.9% |
| Q1 FY2026 | Mar 31, 2026 | $5.13M | -8.7% |
| Q4 FY2025 | Dec 31, 2025 | $4.82M | -6.8% |
| Q3 FY2025 | Sep 30, 2025 | $5.28M | +2.0% |
| Q2 FY2025 | Jun 30, 2025 | $5.55M | -0.8% |
| Q1 FY2025 | Mar 31, 2025 | $5.62M | +4.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.17M | -4.0% |
| Q3 FY2024 | Sep 30, 2024 | $5.18M | -8.2% |
| Q2 FY2024 | Jun 30, 2024 | $5.59M | -3.3% |
| Q1 FY2024 | Mar 31, 2024 | $5.37M | +0.5% |
| Q4 FY2023 | Dec 31, 2023 | $5.39M | +5.0% |
| Q3 FY2023 | Sep 30, 2023 | $5.64M | +11.9% |
| Q2 FY2023 | Jun 30, 2023 | $5.79M | +6.8% |
| Q1 FY2023 | Mar 31, 2023 | $5.34M | -2.9% |
| Q4 FY2022 | Dec 31, 2022 | $5.14M | +3.8% |
| Q3 FY2022 | Sep 30, 2022 | $5.04M | -10.1% |
| Q2 FY2022 | Jun 30, 2022 | $5.42M | -10.0% |
| Q1 FY2022 | Mar 31, 2022 | $5.50M | +4.0% |
| Q4 FY2021 | Dec 31, 2021 | $4.95M | -15.5% |
| Q2 FY2021 | Jun 30, 2021 | $5.61M | -17.3% |
| Q1 FY2021 | Mar 31, 2021 | $6.02M | -12.5% |
| Q4 FY2020 | Dec 31, 2020 | $5.29M | -20.1% |
| Q3 FY2020 | Sep 30, 2020 | $5.85M | -29.2% |
| Q2 FY2020 | Jun 30, 2020 | $6.78M | -20.6% |
| Q1 FY2020 | Mar 31, 2020 | $6.88M | -20.6% |
| Q4 FY2019 | Dec 31, 2019 | $6.62M | -15.1% |
| Q3 FY2019 | Sep 30, 2019 | $8.26M | -5.3% |
| Q2 FY2019 | Jun 30, 2019 | $8.54M | +1.5% |
| Q1 FY2019 | Mar 31, 2019 | $8.66M | +16.0% |
| Q4 FY2018 | Dec 31, 2018 | $7.80M | +13.6% |
| Q3 FY2018 | Sep 30, 2018 | $8.73M | +9.7% |
| Q2 FY2018 | Jun 30, 2018 | $8.42M | +10.5% |
| Q1 FY2018 | Mar 31, 2018 | $7.47M | -4.9% |
| Q4 FY2017 | Dec 31, 2017 | $6.86M | -2.6% |
| Q3 FY2017 | Sep 30, 2017 | $7.95M | +5.5% |
| Q2 FY2017 | Jun 30, 2017 | $7.61M | -3.1% |
| Q1 FY2017 | Mar 31, 2017 | $7.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.05M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.54M | – |
| Q2 FY2016 | Jun 30, 2016 | $7.86M | – |
See a number that looks wrong?